The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family
- PMID: 15059623
- DOI: 10.1016/j.ymgme.2004.01.012
The molecular basis of succinic semialdehyde dehydrogenase deficiency in one family
Abstract
Succinic semialdehyde dehydrogenase (SSADH) deficiency has predominantly neurological consequences, affecting psychomotor, speech and language development. Recently, two clinical reviews summarized the features of this disease and their relative frequency [Neurology 60 (2003) 1413; Ann. Neurol. 54 (2003) S73]. The molecular genetics of SSADH deficiency is still being explored. We describe the molecular basis of this defect in a Tunisian female child presenting with a mild phenotype. A small scale deletion in exon 10 of the gene led to a frameshift that predicts premature termination of the resulting putative protein. The parents were shown to be heterozygotes for this deletion, supporting its causative role.
Similar articles
-
Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria).Am J Hum Genet. 1998 Aug;63(2):399-408. doi: 10.1086/301964. Am J Hum Genet. 1998. PMID: 9683595 Free PMC article.
-
Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency.Clin Neurophysiol. 2004 Jun;115(6):1417-22. doi: 10.1016/j.clinph.2004.01.002. Clin Neurophysiol. 2004. PMID: 15134710
-
Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.Ann Neurol. 2003;54 Suppl 6:S66-72. doi: 10.1002/ana.10626. Ann Neurol. 2003. PMID: 12891656 Review.
-
4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.Neuropediatrics. 1998 Feb;29(1):14-22. doi: 10.1055/s-2007-973527. Neuropediatrics. 1998. PMID: 9553943 Review.
-
Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.Ann Neurol. 2003 Nov;54(5):686-9. doi: 10.1002/ana.10752. Ann Neurol. 2003. PMID: 14595661
Cited by
-
Redox-switch modulation of human SSADH by dynamic catalytic loop.EMBO J. 2009 Apr 8;28(7):959-68. doi: 10.1038/emboj.2009.40. Epub 2009 Mar 19. EMBO J. 2009. PMID: 19300440 Free PMC article.
-
The X-ray crystal structure of Escherichia coli succinic semialdehyde dehydrogenase; structural insights into NADP+/enzyme interactions.PLoS One. 2010 Feb 18;5(2):e9280. doi: 10.1371/journal.pone.0009280. PLoS One. 2010. PMID: 20174634 Free PMC article.
-
Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency.Mol Genet Metab. 2024 May;142(1):108363. doi: 10.1016/j.ymgme.2024.108363. Epub 2024 Mar 4. Mol Genet Metab. 2024. PMID: 38452608 Free PMC article.
-
Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.Hum Genomics. 2009 Jan;3(2):106-20. doi: 10.1186/1479-7364-3-2-106. Hum Genomics. 2009. PMID: 19164088 Free PMC article. Review.
-
Incidence and Geographic Distribution of Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency.JIMD Rep. 2017;34:111-115. doi: 10.1007/8904_2016_14. Epub 2016 Nov 5. JIMD Rep. 2017. PMID: 27815844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources